Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Harris Associates Concentrated Strategy Tony Coniaris | “Centene was a contributor during the quarter. Shares of the U.S.-headquartered managed care company rallied sharply after it reported better than expected first-quarter results. Managed care industry profitability has been under pressure over the last 2 years amidst an unprecedented spike in medical cost trend. However, there are signs that cost trend is now stabilizing or even decelerating in certain utilization categories. We expect easing medical costs combined with improving reimbursement rates and Centene's own expense initiatives to drive a meaningful earnings recovery in the coming years. Beyond this cyclical recovery, we believe Centene remains well positioned for growth as a leader in government managed care.” | BULL | Q2 2026 Jul 28, 2026 | View Pitch |
Hotchkis & Wiley Mid-Cap Value Fund George Davis | “Centene Corp. (CNC) is a managed care organization focused on the Medicaid market, with approximately 28 million at-risk enrollees and the largest Medicaid market share among publicly traded peers. We own it as the clear scale leader in a capital-light business well positioned to benefit as the U.S. continues shifting healthcare toward government-funded, cost-controlled programs. Centene outperformed sharply this quarter as adjusted EPS beat consensus by 48%, management raised full-year guidance, and investors gained confidence that the Medicaid margin recovery and ACA membership reset were both tracking ahead of plan.” | BULL | Q2 2026 Jul 28, 2026 | View Pitch |
Oakmark Select Fund William C. Nygren | “Centene was the top contributor during the quarter. Shares of the U.S.-headquartered managed care company rallied sharply after it reported better than expected first-quarter results. Managed care industry profitability has been under pressure over the last 2 years amidst an unprecedented spike in medical cost trend. However, there are signs that cost trend is now stabilizing or even decelerating in certain utilization categories. We expect easing medical costs combined with improving reimbursement rates and Centene's own expense initiatives to drive a meaningful earnings recovery in the coming years. Beyond this cyclical recovery, we believe Centene remains well positioned for growth as a leader in government managed care.” | BULL | Q2 2026 Jul 15, 2026 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
